Vanessa Carregaro1, José M Ribeiro2, Jesus G Valenzuela2, Djalma L Souza-Júnior1, Diego L Costa1, Carlo J F Oliveira3, Laís A Sacramento1, Manuela S L Nascimento1, Cristiane M Milanezi1, Fernando Q Cunha4, João S Silva1. 1. Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. 2. Section of Vector Biology, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Vector Molecular Biology Unit, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. 3. Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Brazil. 4. Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Abstract
BACKGROUND: Sand fly saliva plays a crucial role in establishing Leishmania infection. We identified adenosine (ADO) and adenosine monophosphate (AMP) as active pharmacologic compounds present in Phlebotomus papatasi saliva that inhibit dendritic cell (DC) functions through a PGE2/IL 10-dependent mechanism. METHODOLOGY/PRINCIPAL FINDINGS: Herein, we prepared a mixture of ADO and AMP in equimolar amounts similar to those present in the salivary-gland extract (SGE) form one pair of salivary glands of P. papatasi and co-injected it with Leishmania amazonensis or L. major into mouse ears. ADO+AMP mimicked exacerbative effects of P. papatasi saliva in leishmaniasis, increasing parasite burden and cutaneous lesions. Enzymatic catabolism of salivary nucleosides reversed the SGE-induced immunosuppressive effect associated with IL-10 enhancement. Immunosuppressive factors COX2 and IL-10 were upregulated and failed to enhance ear lesion and parasite burden in IL 10-/- infected mice. Furthermore, nucleosides increased regulatory T cell (Treg) marker expression on CD4+CD25- cells, suggesting induction of Tregs on effector T cells (T eff). Treg induction (iTreg) was associated with nucleoside-induced tolerogenic dendritic cells (tDCs) expressing higher levels of COX2 and IL-10. In vitro generation of Tregs was more efficient in DCs treated with nucleosides. Suppressive effects of nucleosides during cutaneous leishmaniasis were mediated through an A2AR-dependent mechanism. Using BALB/c mice deficient in A2A ADO receptor (A2AR-/-), we showed that co-inoculated mice controlled infection, displaying lower parasite numbers at infection sites and reduced iTreg generation. CONCLUSION/SIGNIFICANCE: We have demonstrated that ADO and AMP in P. papatasi saliva mediate exacerbative effects of Leishmania infection by acting preferentially on DCs promoting a tolerogenic profile in DCs and by generating iTregs in inflammatory foci through an A2AR mechanism.
BACKGROUND: Sand fly saliva plays a crucial role in establishing Leishmania infection. We identified adenosine (ADO) and adenosine monophosphate (AMP) as active pharmacologic compounds present in Phlebotomus papatasi saliva that inhibit dendritic cell (DC) functions through a PGE2/IL 10-dependent mechanism. METHODOLOGY/PRINCIPAL FINDINGS: Herein, we prepared a mixture of ADO and AMP in equimolar amounts similar to those present in the salivary-gland extract (SGE) form one pair of salivary glands of P. papatasi and co-injected it with Leishmania amazonensis or L. major into mouse ears. ADO+AMP mimicked exacerbative effects of P. papatasi saliva in leishmaniasis, increasing parasite burden and cutaneous lesions. Enzymatic catabolism of salivarynucleosides reversed the SGE-induced immunosuppressive effect associated with IL-10 enhancement. Immunosuppressive factors COX2 and IL-10 were upregulated and failed to enhance ear lesion and parasite burden in IL 10-/- infected mice. Furthermore, nucleosides increased regulatory T cell (Treg) marker expression on CD4+CD25- cells, suggesting induction of Tregs on effector T cells (T eff). Treg induction (iTreg) was associated with nucleoside-induced tolerogenic dendritic cells (tDCs) expressing higher levels of COX2 and IL-10. In vitro generation of Tregs was more efficient in DCs treated with nucleosides. Suppressive effects of nucleosides during cutaneous leishmaniasis were mediated through an A2AR-dependent mechanism. Using BALB/c mice deficient in A2A ADO receptor (A2AR-/-), we showed that co-inoculated mice controlled infection, displaying lower parasite numbers at infection sites and reduced iTreg generation. CONCLUSION/SIGNIFICANCE: We have demonstrated that ADO and AMP in P. papatasisaliva mediate exacerbative effects of Leishmania infection by acting preferentially on DCs promoting a tolerogenic profile in DCs and by generating iTregs in inflammatory foci through an A2AR mechanism.
Authors: Raquel de Oliveira Lopes; Nelilma Correia Romeiro; Cleverton Kleiton F de Lima; Leandro Louback da Silva; Ana Luisa Palhares de Miranda; Paulo Gustavo B D Nascimento; Fernando Q Cunha; Eliezer J Barreiro; Lídia Moreira Lima Journal: Eur J Med Chem Date: 2012-05-14 Impact factor: 6.514
Authors: Paula B Donate; Thiago M Cunha; Waldiceu A Verri; Cristina M Junta; Flavia O Lima; Silvio M Vieira; Rafael S Peres; Karina F Bombonato-Prado; Paulo Louzada; Sergio H Ferreira; Eduardo A Donadi; Geraldo A S Passos; Fernando Q Cunha Journal: Inflamm Res Date: 2012-01-17 Impact factor: 4.575
Authors: T H Gasparoto; C E de Oliveira; N A Vieira; V C Porto; F Q Cunha; G P Garlet; A P Campanelli; V S Lara Journal: Eur J Clin Microbiol Infect Dis Date: 2011-11-26 Impact factor: 3.267
Authors: Makoto Naganuma; Elizabeth B Wiznerowicz; Courtney M Lappas; Joel Linden; Mark T Worthington; Peter B Ernst Journal: J Immunol Date: 2006-09-01 Impact factor: 5.422
Authors: Vanessa Carregaro; Jesus G Valenzuela; Thiago M Cunha; Waldiceu A Verri; Renata Grespan; Graziela Matsumura; José M C Ribeiro; Dia-Eldin Elnaiem; João S Silva; Fernando Q Cunha Journal: J Leukoc Biol Date: 2008-04-07 Impact factor: 4.962
Authors: Diego L Costa; Vanessa Carregaro; Djalma S Lima-Júnior; Neide M Silva; Cristiane M Milanezi; Cristina R Cardoso; Ângela Giudice; Amélia R de Jesus; Edgar M Carvalho; Roque P Almeida; João S Silva Journal: PLoS Negl Trop Dis Date: 2011-03-01
Authors: Adrian R Kendal; Ye Chen; Frederico S Regateiro; Jianbo Ma; Elizabeth Adams; Stephen P Cobbold; Shohei Hori; Herman Waldmann Journal: J Exp Med Date: 2011-08-29 Impact factor: 14.307
Authors: Juliana C Costa-Madeira; Gabrielly B Trindade; Paulo H P Almeida; João S Silva; Vanessa Carregaro Journal: Front Immunol Date: 2022-05-02 Impact factor: 8.786
Authors: Vanessa Carregaro; Marcelo H Napimoga; Raphael S Peres; Luciana Benevides; Laís Amorim Sacramento; Larissa G Pinto; Renata Grespan; Thiago M Cunha; João Santana da Silva; Fernando Q Cunha Journal: Mediators Inflamm Date: 2016-10-31 Impact factor: 4.711
Authors: Elen Anatriello; Carlo José Freire Oliveira; Nathália Baptista Oliveira; Andressa Fisch; Cristiane Maria Milanezi; João Santana da Silva; Isabel Kinney Ferreira de Miranda-Santos; Beatriz Rossetti Ferreira Journal: Parasit Vectors Date: 2017-07-10 Impact factor: 3.876
Authors: Mikhael H F Lima; Lais A Sacramento; Gustavo F S Quirino; Marcela D Ferreira; Luciana Benevides; Alynne K M Santana; Fernando Q Cunha; Roque P Almeida; João S Silva; Vanessa Carregaro Journal: Front Immunol Date: 2017-07-20 Impact factor: 7.561